Clover Leaf Capital Corp. (CLOE): Marketing Mix Analysis [Dec-2025 Updated]

You're trying to make sense of a Special Purpose Acquisition Company (SPAC) that's reached the end of the road, and honestly, analyzing the marketing mix for Clover Leaf Capital Corp. (CLOE) in late 2025 is a fascinating exercise in corporate dissolution. Forget growth strategies; the core 'product' now is the right to a cash redemption, with the stock trading around \$12.47-a premium to the initial \$10.00 IPO price, yet below the expected \$12.59 trust value. We need to see how their 'Place' (the OTC market) and 'Promotion' (SEC filings about the wind-down) reflect this final stage, so stick around as we map out the four P's for this unique, liquidating entity.

Clover Leaf Capital Corp. (CLOE) - Marketing Mix: Product

You're looking at the product offering for Clover Leaf Capital Corp. (CLOE) right now, and honestly, the product has fundamentally shifted from an acquisition vehicle to a wind-down process. The core product, as a publicly traded entity, was a special purpose acquisition company (SPAC).

The primary offering you are dealing with now is the right to a cash redemption of the Class A common stock originally issued during the Initial Public Offering (IPO). This redemption is against the funds held in the trust account. For instance, in a prior redemption event related to an extension vote in January 2024, holders redeemed 202,360 shares for approximately $11.71 per share, totaling about $2,369,636 removed from the Trust Account. The original warrant exercise price, which is now largely moot given the liquidation, was set at $11.50 per share.

The initial strategic focus, the intended product for the SPAC to acquire, was centered on businesses within the legalized cannabis industry. However, following the mutual termination of the merger agreement with Kustom Entertainment, Inc. on November 7, 2024, the company announced its definitive intention to liquidate. So, the current product lifecycle stage is company liquidation and dissolution.

Here's a quick look at the structure that underpinned the original offering and the current redemption value basis:

The product's features, in the context of a SPAC, are defined by the structure of the securities offered at the IPO. You should note these key structural elements:

• The core product is a publicly traded shell company (SPAC).
• Primary offering is the right to a cash redemption of Class A common stock.
• The original target focus was on businesses in the legalized cannabis industry.
• The current product lifecycle stage is company liquidation and dissolution.
• The company was incorporated in 2021 and is based in Miami, Florida.
• The sponsor is controlled by Yntegra Capital Investments, LLC.

The value proposition now is purely the return of capital from the trust account, less any expenses incurred prior to the liquidation decision made in November 2024. Any outstanding warrants, trading under the symbol CLOER, are also subject to the liquidation terms, though the primary focus for current holders is the Class A common stock redemption. The company's management team, which included Romeo Gajda as Chairman and CEO and Robert Hulla as CFO at inception, is now executing the dissolution plan.

Clover Leaf Capital Corp. (CLOE) - Marketing Mix: Place

You're looking at the distribution strategy for Clover Leaf Capital Corp., which, as a Special Purpose Acquisition Company (SPAC), is less about physical product placement and more about the venue where its securities are made available to investors. The 'place' here is the financial marketplace.

The primary distribution channel for Clover Leaf Capital Corp. securities is the public market, specifically the Over-The-Counter (OTC) market. The Class A common stock trades under the ticker CLOE, while the units originally traded under CLOEU. This signifies that the company's shares are accessible to a broad range of investors through brokerage platforms that facilitate OTC trading.

The corporate presence, which dictates administrative and legal accessibility, is anchored in the United States. The company's official headquarters are located in Miami, Florida. This location serves as the central point for corporate governance and investor relations correspondence.

The initial market placement involved a structured offering process. Public shares were originally sold as units in an Initial Public Offering (IPO). The closing of this IPO on July 22, 2021, involved the sale of 13,831,230 units at an offering price of $10.00 per unit, ultimately raising approximately $138.3 million including the over-allotment option exercise. Each unit initially comprised one share of Class A common stock and one right.

Trading activity in late 2025 shows extremely limited liquidity, which is a critical factor in the 'Place' strategy for a thinly traded security. Trading volume is very low, recently reported at 0.00 on November 28, 2025. This contrasts with the average daily volume, which was reported at 161.88 shares for the CLOEU units around November 27, 2025.

Here's a quick look at the key distribution and location metrics as of the latest available data points:

The accessibility of Clover Leaf Capital Corp. stock is defined by its listing environment and the structure of its security offerings. The separation of units into stock (CLOE) and rights (CLOER) starting September 9, 2021, provided different avenues for market participation.

The distribution points for official company information, which supports investor access and transparency, include:

• SEC website for filings like the Form S-1.
• Corporate contact address: 1450 Brickell Avenue, Suite 1420, Miami, FL 33131.
• Proxy solicitor contact for specific meeting information.
• The company's official website for press releases.

The company's focus as a blank check entity means its ultimate 'place' in the market is contingent on a successful business combination, which is the intended final distribution of its trust assets to shareholders or the merged entity's structure.

Clover Leaf Capital Corp. (CLOE) - Marketing Mix: Promotion

You're looking at how Clover Leaf Capital Corp. communicated its status, especially after the SPAC process pivoted toward liquidation. Promotion here isn't about selling a product; it's about managing shareholder expectations and fulfilling disclosure requirements during a wind-down phase. Honestly, the promotional focus shifts entirely to compliance and return of capital.

The communication strategy, as evidenced by public filings and announcements, centered on major corporate events, using formal channels to reach the target audience-the stockholders.

Investor relations focused heavily on the liquidation and redemption process following the merger termination. The Board determined to liquidate the Company and expected to redeem all outstanding shares of Class A common stock sold in the initial public offering. This intent was announced on November 8, 2024, with the expectation that additional information on the redemption process would follow in the coming days.

Public communication included mandatory filings detailing the end of the proposed business combination. The termination of the Agreement and Plan of Merger with Kustom Entertainment, effective November 7, 2024, was described in a Current Report on Form 8-K to be filed by Clover Leaf Capital Corp. This action also led to the cancellation of the special meeting originally scheduled for November 8, 2024, and the withdrawal of related proposals from stockholder consideration, which were detailed in the definitive proxy statement filed with the SEC on July 31, 2024.

The communication efforts surrounding the failed merger involved specific quantitative elements:

The use of a proxy solicitor, Morrow Sodali LLC, was a key tactic during the preceding SPAC process for stockholder communication. They provided direct contact channels for assistance, which is critical for ensuring proxy votes are cast correctly or for handling redemption inquiries.

Here are the contact details provided by Morrow Sodali LLC for shareholder assistance:

• Toll-free call: 800-662-5200
• Email for stockholders: CLOE.info
• Collect call for banks/brokers: 203-658-9400
• Email for banks/brokers: CLOE.info@investor.morrowsodali.com

Still, Clover Leaf Capital Corp. engaged in forward-looking investor outreach even after the liquidation decision. The company participated in a conference call with Roth Capital on November 26, 2025. This call featured Co-Founder COO Janous and Sustainability Analyst Shen discussing the macro outlook and supply-demand dynamics for AI/datacenters and renewables versus alternatives. This type of engagement is standard for SPACs, even post-termination, to keep institutional contacts informed about the management team's perspective on the broader market, though the context is now liquidation.

For context on the Roth Capital platform, their Annual ROTH Conference typically provides a venue for executive management from approximately 500 private and public companies to meet with institutional investors.

Clover Leaf Capital Corp. (CLOE) - Marketing Mix: Price

You're looking at the pricing structure for Clover Leaf Capital Corp. (CLOE) as of late 2025. For a Special Purpose Acquisition Company (SPAC), the 'price' is primarily defined by the trading value of its common stock and the redemption value tied to its trust account, which is critical for investor accessibility and perceived value.

Here's the quick math on the current market valuation metrics:

• Current stock price is approximately $12.47 as of late November 2025.
• Market capitalization is approximately $61.91 million.
• Expected redemption price is near the trust value, previously around $12.59 per share.
• The initial public offering price for units was $10.00 per unit.
• Trailing twelve months (ttm) Net Income was negative -$1.17 million as of March 2025.

The pricing strategy for a SPAC is inherently linked to its liquidation preference, which underpins the redemption price. This sets a floor, or at least a strong expectation, for what shareholders can expect if a business combination isn't completed by the deadline. The initial offering price established the starting point for this structure.

Consider these key historical and current financial metrics that frame the current trading price:

The company's financial performance directly influences investor perception of value, even for a shell company. The negative profitability figures suggest that the price is being driven more by the trust value and the potential for a future transaction, rather than current operational earnings. The stock trades on the PNK (Other OTC) exchange as of late 2025, following a planned delisting from Nasdaq.

Here are some concrete financial indicators related to the negative pricing environment:

• EPS (Trailing Twelve Months): ($0.23).
• Net Income (ttm): -$1.17 million as of March 2025.
• Return on Equity (ROE): -21.74%.
• Return on Capital (ROC): -24.73%.
• Enterprise Value: $66.52 million.

The market capitalization has seen a significant contraction since the IPO, decreasing from $179.22M in September 2021 to the current $61.91M. Still, the current stock price of $12.47 is above the original $10.00 unit price, reflecting some premium over the initial capital invested, though it is below the historical redemption reference of $12.59.

Finance: draft 13-week cash view by Friday.